Therefore, our study aimed to assess the potential role of miR-15b-5p and Toll-like receptor 4 as biomarkers for the diagnosis of HCC in the sera of Egyptian patients with HCV and/or cirrhosis. This evidence concerns the gene TLR4 and Cirrhosis.